[go: up one dir, main page]

WO2000020604A3 - Molecules d'oxydoreductase - Google Patents

Molecules d'oxydoreductase Download PDF

Info

Publication number
WO2000020604A3
WO2000020604A3 PCT/US1999/023434 US9923434W WO0020604A3 WO 2000020604 A3 WO2000020604 A3 WO 2000020604A3 US 9923434 W US9923434 W US 9923434W WO 0020604 A3 WO0020604 A3 WO 0020604A3
Authority
WO
WIPO (PCT)
Prior art keywords
oxre
provides
molecules
oxidoreductase molecules
oxidoreductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/023434
Other languages
English (en)
Other versions
WO2000020604A2 (fr
Inventor
Preeti Lal
Karl J Guegler
Gina A Gorgone
Neil C Corley
Mariah R Baughn
Y Tom Tang
Jennifer L Hillman
Olga Bandman
Yalda Azimzai
Janice Au-Young
Henry Yue
Dyung Aina M Lu
Junming Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to US09/806,536 priority Critical patent/US6808895B1/en
Priority to JP2000574699A priority patent/JP2003521871A/ja
Priority to AU62953/99A priority patent/AU6295399A/en
Priority to CA002344973A priority patent/CA2344973A1/fr
Priority to EP99950258A priority patent/EP1119629A2/fr
Publication of WO2000020604A2 publication Critical patent/WO2000020604A2/fr
Publication of WO2000020604A3 publication Critical patent/WO2000020604A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention se rapporte à des molécules d'oxydoréductase humaines (OXRE) et à des polynucléotides qui identifient et codent pour ces OXRE. L'invention se rapporte également à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Elle se rapporte en outre à des méthodes permettant de diagnostiquer, de traiter ou de prévenir les troubles associés à l'expression de OXRE.
PCT/US1999/023434 1998-10-06 1999-10-06 Molecules d'oxydoreductase Ceased WO2000020604A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/806,536 US6808895B1 (en) 1999-10-06 1999-10-06 DNA encoding oxidoreductase and polypeptide encoded thereby
JP2000574699A JP2003521871A (ja) 1998-10-06 1999-10-06 酸化還元酵素分子
AU62953/99A AU6295399A (en) 1998-10-06 1999-10-06 Oxidoreductase molecules
CA002344973A CA2344973A1 (fr) 1998-10-06 1999-10-06 Molecules d'oxydoreductase
EP99950258A EP1119629A2 (fr) 1998-10-06 1999-10-06 Molecules d'oxydoreductase

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US16751998A 1998-10-06 1998-10-06
US17222798A 1998-10-06 1998-10-06
US60/172,227 1998-10-06
US20499998A 1998-12-02 1998-12-02
US15520298P 1998-12-02 1998-12-02
US60/155,202 1998-12-02
US12391199P 1999-03-10 1999-03-10
US60/123,911 1999-03-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/893,888 Division US20050053987A1 (en) 1998-10-06 2004-07-20 Oxidoreductase molecules

Publications (2)

Publication Number Publication Date
WO2000020604A2 WO2000020604A2 (fr) 2000-04-13
WO2000020604A3 true WO2000020604A3 (fr) 2000-08-10

Family

ID=27537680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/023434 Ceased WO2000020604A2 (fr) 1998-10-06 1999-10-06 Molecules d'oxydoreductase

Country Status (1)

Country Link
WO (1) WO2000020604A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE342975T1 (de) * 1998-11-23 2006-11-15 Centre Nat Rech Scient Apoptosis induzierender faktor
US6773911B1 (en) 1998-11-23 2004-08-10 Amgen Canada Inc. Apoptosis-inducing factor
US6174682B1 (en) * 1999-03-08 2001-01-16 Millenium Pharmaceuticals, Inc. Thioredoxin family active site molecules and uses therefor
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
WO2001079504A1 (fr) * 2000-04-13 2001-10-25 Millennium Pharmaceuticals, Inc. 23155, nouvelle proteine humaine 5-$g(a) reductases et ses utilisations
AU2002211324A1 (en) * 2000-09-29 2002-04-08 Incyte Genomics, Inc. Oxidoreductases
JP2004528045A (ja) * 2001-06-05 2004-09-16 エクセリクシス・インコーポレイテッド ｐ５３経路のモディファイヤーとしてのＰ５ＣＲｓおよび使用方法
US20040106119A1 (en) * 2002-04-19 2004-06-03 Pedro Alzari Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variants
WO2006122214A2 (fr) 2005-05-10 2006-11-16 Health Research Inc. Nouvelle 5-alpha-steroide-reductase

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0712932A2 (fr) * 1994-11-18 1996-05-22 Sumitomo Chemical Company, Limited Monooxygénase humaine contenant flavine
WO1998039446A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 70 proteines humaines secretees
WO1999014328A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO1999038881A1 (fr) * 1998-01-30 1999-08-05 Human Genome Sciences, Inc. 67 proteines humaines secretees

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0712932A2 (fr) * 1994-11-18 1996-05-22 Sumitomo Chemical Company, Limited Monooxygénase humaine contenant flavine
WO1998039446A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 70 proteines humaines secretees
WO1999014328A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques les codant
WO1999038881A1 (fr) * 1998-01-30 1999-08-05 Human Genome Sciences, Inc. 67 proteines humaines secretees

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002129602, Database accession no. AL080080 *

Also Published As

Publication number Publication date
WO2000020604A2 (fr) 2000-04-13

Similar Documents

Publication Publication Date Title
WO1999036550A3 (fr) Molecules de proteases humaines
WO2001012662A3 (fr) Proteines associees a la membrane
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2000034477A3 (fr) Proteines associees a des neurones
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000012711A3 (fr) Proteines membranaires de canal humaines
WO1999057144A3 (fr) Molecules de regulateur de transcription humaine
WO2000009709A3 (fr) Proteases et proteines associees
WO2000012703A3 (fr) Molecules associees au transport de proteines
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2000014251A3 (fr) Transferases humaines
WO2000005374A3 (fr) Molecules associees a une proliferation cellulaire
WO2000000594A3 (fr) Transferases humaines
WO2000020604A3 (fr) Molecules d'oxydoreductase
WO2001044448A3 (fr) Proteines d'oxydoreductase humaines
WO2001032888A3 (fr) Molecules humaines de la transferase
WO1999041373A3 (fr) Molecules humaines associees au transport
WO1999057270A3 (fr) Molecules de recepteur humain
WO2000028045A3 (fr) Hydrolases humaines
WO2000042201A3 (fr) Peptidases humaines
WO1999038981A3 (fr) Molecules de proteine kinase humaines
WO1999049037A3 (fr) Molecules apparentees a la proteine-phosphatase
WO2000008155A3 (fr) Proteines associees a un recepteur humain
WO2000011171A3 (fr) Proteines humaines associees a l'arn

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09806536

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2344973

Country of ref document: CA

Ref country code: CA

Ref document number: 2344973

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 574699

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999950258

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999950258

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999950258

Country of ref document: EP